Immunology & Cell Biology (ICB)

Immunology & Cell Biology (ICB) is a long-established, peer-reviewed scientific journal published by John Wiley & Sons in partnership with the Australian and New Zealand Society for Immunology (ASI). It traces its origins to 1924, making it one of the oldest specialised journals in immunology, originally launched as the Australian Journal of Experimental Biology and Medical Science and later evolving into Immunology & Cell Biology in 1987 with a stronger focus on immune system biology. The journal publishes high-quality original research articles, reviews, commentaries, and perspectives that explore fundamental and innovative aspects of the immune system and its cellular mechanisms. Its scope includes studies on innate and adaptive immunity, immune responses to pathogens, tumour immunology, immune dysfunction and immunopathology, immunogenetics, and experimental models in humans and other organisms. ICB serves an international audience of immunologists, cell biologists, clinicians, and biomedical researchers by disseminating cutting-edge findings that deepen understanding of immune processes and their implications for disease treatment and human health. The journal emphasises scientific rigor, relevance, and contribution to both basic immunological knowledge and clinical translation. It is indexed in major scientific databases and maintains a reputable impact in the fields of immunology and cellular biology.

Immunology & Cell Biology (ICB) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cell Biology, Immunology, Immunology and Allergy, basic and translational research spanning cellular immunity, innate and adaptive immune responses, immunopathology, immunogenetics, tumour immunology, immunotherapy , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0818-9641, E-ISSN: 1440-1711, Established: 1924, Impact Factor: 3.0
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE